The guideline acts "as an adjunct to the already existing and excellent American Heart Association guidelines by adding information in areas that rheumatologists may play a role."
The landmark case will have much to teach; still, it turns back the clock to a time when immunosuppression was especially intense because we really didn t know what to expect.
The biologic was associated with reduced infection risk when compared with anti-TNF agents or tofacitinib in a real-world analysis of nearly 90 million patients.
The CDC contacted pharmacies on Wednesday to reinforce the message that people with moderate to severe immune suppression should receive a fourth COVID-19 vaccine.